MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Advaxis Company Profile (NASDAQ:ADXS)

Consensus Ratings for Advaxis (NASDAQ:ADXS) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $24.80 (201.34% upside)

Analysts' Ratings History for Advaxis (NASDAQ:ADXS)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016HC WainwrightReiterated RatingBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016FBR & Co.Reiterated RatingOutperform$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016BarclaysLower Price TargetOverweight$30.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Janney Montgomery ScottReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2015GuggenheimInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015MLV & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015AegisReiterated RatingBuy -> PositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Advaxis (NASDAQ:ADXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
4/13/2016        
4/16/2015($0.31)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/23/2014($0.25)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Advaxis (NASDAQ:ADXS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.61)($0.61)($0.61)
Q3 20161($0.55)($0.55)($0.55)
Q4 20161($0.55)($0.55)($0.55)
(Data provided by Zacks Investment Research)
Dividend History for Advaxis (NASDAQ:ADXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Advaxis (NASDAQ:ADXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016Thomas J MckearnDirectorSell4,100$7.45$30,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Daniel O'connorCEOSell8,237$7.51$61,859.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Robert PetitInsiderSell2,785$7.51$20,915.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Robert PetitInsiderSell3,325$9.13$30,357.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Thomas J MckearnDirectorSell14,000$8.25$115,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Sara BonsteinCFOSell15,037$5.58$83,906.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2016Daniel O'connorCEOSell8,818$6.88$60,667.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2016Robert PetitinsiderSell3,099$6.88$21,321.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Gregory T MayesCOOSell19,231$11.63$223,656.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/20/2015David J MauroInsiderSell24,586$10.08$247,826.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Adage Capital Partners Gp LlcMajor ShareholderBuy300,000$14.15$4,245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2015Adage Capital Partners Gp LlcMajor ShareholderBuy500,000$19.00$9,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Adage Capital Partners Gp LlcMajor ShareholderBuy684,762$7.50$5,135,715.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Richard J BermanDirectorSell14,530$2.63$38,213.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2014Daniel O'connorCEOBuy3,333$3.00$9,999.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Daniel O'connorCEOBuy13,500$4.00$54,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Mark J RosenblumCFOBuy12,000$4.00$48,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Robert PetitInsiderBuy12,800$4.00$51,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Roni AppelDirectorBuy12,500$4.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Advaxis (NASDAQ:ADXS)
DateHeadline
06/29/16 07:28 PMTrading Session Share Performance Focus on: Advaxis, Inc. (NASDAQ:ADXS) - Telanagana Press
06/29/16 07:28 PMAdvaxis, Inc. (NASDAQ:ADXS) Stock Performance and Session Recap - Engelwood Daily
06/29/16 02:18 PMWill Advaxis, Inc. (NASDAQ:ADXS) Surprise Analysts? - Investor Newswire
06/29/16 02:18 PMRecently Issued Stock Ratings For Advaxis, Inc. (ADXS) - Fiscal Standard
06/28/16 07:43 PMAdvaxis, Inc. (NASDAQ:ADXS)View on Wall Street Analyst Ratings - Engelwood Daily
06/28/16 07:43 PMAdvaxis, Inc. (NASDAQ:ADXS)'s Company Shares Decreased 19.25% After High Volatility - Press Telegraph
06/28/16 02:33 PMCheck on Share Volatility: Advaxis, Inc. (NASDAQ:ADXS) - Engelwood Daily
06/28/16 02:33 PMAdvaxis, Inc. (NASDAQ:ADXS): Reviewing Stock Performance - Press Telegraph
06/28/16 02:33 PMStock Performance in Review: Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/28/16 02:33 PMTarget Price Consensus Focus on Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/28/16 02:33 PMFocus Stock Recap for: Advaxis, Inc. (NASDAQ:ADXS) - Telanagana Press
06/28/16 02:33 PMMonitoring Target Price Consensus for: Advaxis, Inc. (NASDAQ:ADXS) - Telanagana Press
06/28/16 07:31 AMCovering the Bases on Advaxis, Inc. (NASDAQ:ADXS): Where is the Stock Going? - Press Telegraph
06/27/16 02:41 PMActive Company Share Review : Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/27/16 07:05 AMStrong Sell Calls Recommendations For Advaxis, Inc. (NASDAQ:ADXS) At 0 - Investor Newswire
06/27/16 07:05 AMNext Weeks Broker Price Targets For Advaxis, Inc. (ADXS) - Fiscal Standard
06/27/16 07:00 AMAdvaxis to Webcast Investor & Analyst Day 2016 - [GlobeNewswire] - PRINCETON, N.J., June 27, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that their annual Investor & Analyst Day, scheduled for Tuesday, ...
06/25/16 02:20 PMAdvaxis, Inc. (NASDAQ:ADXS): Update on Stock Performance - Press Telegraph
06/25/16 09:52 AMAre Analysts Bearish Advaxis, Inc. (NASDAQ:ADXS) After Last Week? - Press Telegraph
06/24/16 02:18 PMTracking Share Activity for: Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/24/16 02:18 PMImpact Score Outlook on:Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/23/16 09:46 PMAdvaxis, Inc. (NASDAQ:ADXS): Share Update and Performance Review - Press Telegraph
06/23/16 09:46 PMStock Watch for: Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/23/16 03:48 PMAdvaxis, Inc. (NASDAQ:ADXS) Broker Rating Update - Engelwood Daily
06/23/16 03:48 PMChecking in on Consensus Views for Advaxis, Inc. (NASDAQ:ADXS) - Press Telegraph
06/21/16 07:07 AMAdvaxis, Inc. (ADXS) Current Analyst Ratings - Fiscal Standard
06/13/16 02:21 PMLatest Price movements of Stocks: Anthem, Inc. (NYSE:ANTM) , Advaxis, Inc. (NASDAQ:ADXS) - Street Updates
06/11/16 12:04 PMADVAXIS, INC. Financials -
06/09/16 08:13 PMHealthcare Analysts Weigh In on Advaxis, Inc. (ADXS) and Insmed Incorporated (INSM) Following ASCO Presentation ... - Smarter Analyst
06/09/16 08:53 AMWhy Advaxis, Inc. Stock Rose 19.6% in May -
06/08/16 10:45 AMStock Update (NASDAQ:ADXS): Advaxis, Inc. Announces First Patient Dosed in Phase 2 Trial Evaluating AXAL in Anal ... - Smarter Analyst
06/08/16 09:40 AMAdvaxis reports 2Q loss -
06/07/16 10:44 AMStocks Analysts Ranking Summary: Gilead Sciences, Inc. (NASDAQ:GILD) , Advaxis, Inc. (NASDAQ:ADXS) - Street Updates
06/07/16 10:44 AMPfizer Inc. (NYSE:PFE) & Advaxis, Inc. (NASDAQ:ADXS) Healthcare Stocks on the Move - Wall Street 24
06/06/16 02:21 PMFriday Trading Recap: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) , Advaxis, Inc. (NASDAQ:ADXS) - Street Updates
06/06/16 06:18 AMAdvaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports - [at noodls] - Durable complete response seen in a recurrent / metastatic cervical cancer patient previously treated with chemoradiation and systemic-dose chemotherapy plus bevacizumab PRINCETON, N.J., June 06, 2016 ...
06/04/16 07:38 PMTarget Price Review Advaxis, Inc. (NASDAQ:ADXS) - HNN
06/04/16 10:45 AMStocks Earnings Overview: Advaxis, Inc. (NASDAQ:ADXS), Lazard Ltd. (NYSE:LAZ) - Beacon Chronicle
06/02/16 08:18 PMAdvaxis, Inc. (NASDAQ:ADXS): Rundown on Share Performance - HNN - Advaxis, Inc. (NASDAQ:ADXS): Rundown on Share PerformanceHNNIn the latest trading period, Advaxis, Inc. (NASDAQ:ADXS) shares have seen a change of +3.81%. During the period, the stock has moved up to a high of $10.03 and dipped to a low of $9.44. Looking at a broader view of stock performance, shares have range ...and more »
06/02/16 08:18 PMAdvaxis, Inc. (NASDAQ:ADXS) Near Term Target Update - Stock Tick Tock - Advaxis, Inc. (NASDAQ:ADXS) Near Term Target UpdateStock Tick TockSell-siders covering shares of Advaxis, Inc. (NASDAQ:ADXS) have a consensus price target of $21.2 for the next 12-18 months. Analysts study the companies they cover in order to present the sell-side institutions with the information needed to make ...and more »
06/02/16 10:58 AMTarget Price Outlook on Advaxis, Inc. (NASDAQ:ADXS) - HNN - Target Price Outlook on Advaxis, Inc. (NASDAQ:ADXS)HNNEquity analysts that track Advaxis, Inc. (NASDAQ:ADXS) shares have provided targets on where they believe the stock will move in the future. The present consensus target price compiled using analysts polled by Zacks Research sits at $21.2. There are 5 ...and more »
06/01/16 02:22 PMActive Stock Review: Advaxis, Inc. (NASDAQ:ADXS) - HNN - Active Stock Review: Advaxis, Inc. (NASDAQ:ADXS)HNNRecent trading activity of Advaxis, Inc.(NASDAQ:ADXS) gets the stock on the active list for today. Shares have changed 1.93% since the open at the time of writing. After a recent look, the stock had hit $9.41. Company shares have been recently noted at ...and more »
06/01/16 10:40 AMAdvaxis, Inc. (ADXS) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Advaxis, Inc. (ADXS) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Advaxis, Inc. (ADXS). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/31/16 02:18 PMShare Rating Focus on Advaxis, Inc. (NASDAQ:ADXS) - HNN - Share Rating Focus on Advaxis, Inc. (NASDAQ:ADXS)HNNPresently, Wall Street analysts have given a consensus stock rating of 1 on shares of Advaxis, Inc. (NASDAQ:ADXS). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...and more »
05/31/16 02:18 PMStock Performance Check on : Advaxis, Inc. (NASDAQ:ADXS) - HNN - Stock Performance Check on : Advaxis, Inc. (NASDAQ:ADXS)HNNTracking share activity in recent trading action, shares of Advaxis, Inc. have been recorded 77.35% away from the 52 week low. Company shares have been recently seen -69.33% off of the 52 week high. The stock has been trading at 42.81% separated from ...and more »
05/28/16 12:09 PMView on Earnings Advaxis, Inc. (NASDAQ:ADXS) - HNN - View on Earnings Advaxis, Inc. (NASDAQ:ADXS)HNNSell-side analysts that cover Advaxis, Inc. (NASDAQ:ADXS) are expecting the company to report earnings for the quarter of $-0.52. The consensus estimate uses covering analysts polled by Zacks Research. The estimate may vary from what other data ...
05/27/16 01:14 PMAdvaxis, Inc. (NASDAQ:ADXS) News Sentiment Review - Wall Street Hints and News - Advaxis, Inc. (NASDAQ:ADXS) News Sentiment ReviewWall Street Hints and NewsAdvaxis, Inc. (NASDAQ:ADXS) has a present news sentiment score of 0.36. This score is given by Beta Research using a scale from 1 to -1. A 1 score may indicate positive news sentiment while a score of -1 may indicate the opposite. Advaxis, Inc.and more »
05/26/16 12:17 PMEarnings Review and Stock Rundown for Advaxis, Inc. (NASDAQ:ADXS) - Wall Street Hints and News - Earnings Review and Stock Rundown for Advaxis, Inc. (NASDAQ:ADXS)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Advaxis, Inc. (NASDAQ:ADXS) to post ...and more »
05/25/16 12:28 PMAdvaxis, Inc. (NASDAQ:ADXS) Impact Score At 50 - Investor Newswire - Advaxis, Inc. (NASDAQ:ADXS) Impact Score At 50Investor NewswireAlpha One explored various online articles released on Advaxis, Inc. (NASDAQ:ADXS), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued on ...and more »
05/19/16 12:18 PMRecent Trading Updates: Advaxis, Inc. (NASDAQ:ADXS) , TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Street Updates - Recent Trading Updates: Advaxis, Inc. (NASDAQ:ADXS) , TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG)Street UpdatesOn 5/18/2016, shares of Advaxis, Inc. (NASDAQ:ADXS) rose +0.93% in trading session and finally closed at $7.63. The company most recent volume stood at 507.57 thousand shares as compared to its average volume of 934.09 thousand shares. Over the ...Current Price Targets For Advaxis, Inc. (ADXS)Risers & FallersBroker Roundup For Advaxis, Inc. (ADXS)Share Trading NewsBiotechnology Bulls: Intec Pharma Ltd. (NASDAQ:NTEC), Advaxis, Inc. (NASDAQ:ADXS), Aduro BioTech, Inc ...KC RegisterThe Post -News Tribuneall 9 news articles »
About Advaxis

Advaxis logoAdvaxis, Inc. is a United States-based clinical-stage biotechnology company. The Company is focused on developing various cancer immunotherapies that use the body's natural immune system to redirect the immune response to kill cancer. Its Lm Technology is a cancer immunotherapy agent shown in preclinical studies to both generate cancer fighting T-cells directed against a cancer antigen, and neutralizes regulatory T cells and myeloid-derived suppressor cells (MDSCs) that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Its Lm Technology immunotherapy, axalimogene filolisbac (ADXS-HPV), targets human papillomavirus (HPV)-associated cancers and is in clinical trials for three indications: Phase II in invasive cervical cancer, Phase I/II in head and neck cancer, and Phase I/II in anal cancer. It has preclinical program with immunotherapies in development for cancers and infectious diseases.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADXS
  • CUSIP:
Key Metrics:
  • Previous Close: $8.23
  • 50 Day Moving Average: $8.34
  • 200 Day Moving Average: $8.27
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $282.67M
  • Current Quarter EPS Consensus Estimate: $-2.08 EPS
Additional Links:
Advaxis (NASDAQ:ADXS) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha